Information  X 
Enter a valid email address

EPIC/TIDM matching 'SLN'

Date
Time Source
Company
Announcement
26 Nov 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Update on AIM Delisting
25 Nov 2021 5:30 pm RNS   FTSE Russell Silence Therapeutics
16 Nov 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Third Quarter 2021 Financial Results
11 Nov 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence to Present at Jefferies London Conference
10 Nov 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
05 Nov 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) New Key Shareholder
01 Nov 2021 5:33 pm RNS Factsheet Silence Therapeutics (SLN) Result of General Meeting
  4:49 pm RNS Factsheet Silence Therapeutics (SLN) Total Voting Rights
28 Oct 2021 4:02 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
21 Oct 2021 1:30 pm RNS Factsheet Silence Therapeutics (SLN) Silence Provides Pipeline Updates at 2021 R&D Day
15 Oct 2021 7:05 am RNS Factsheet Silence Therapeutics (SLN) Proposed Cancellation of Trading on AIM
  7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence and Hansoh Pharma Announce Collaboration
08 Oct 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Block Listing Return
  7:00 am RNS Factsheet Silence Therapeutics (SLN) Total Voting Rights
07 Oct 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence Therapeutics to host R&D day
28 Sep 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Chardan Genetic Medicines Conference Participation
08 Sep 2021 4:03 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
  4:00 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
01 Sep 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence Appoints Senior VP of BD, AM and NPD.
25 Aug 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence to Participate in Investor Conferences
12 Aug 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence Therapeutics Report Half-Year 2021 Results
06 Aug 2021 12:15 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
  12:13 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
05 Aug 2021 2:57 pm RNS Factsheet Silence Therapeutics (SLN) Total Voting Rights
15 Jul 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Notice of half year results
15 Jun 2021 5:54 pm RNS Factsheet Silence Therapeutics (SLN) Results of Annual General Meeting
07 Jun 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence to present SL124 data at EHA
25 May 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) $40m Payment from AstraZeneca for Collaboration
19 May 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Phase 1 Study in Healthy Volunteers Positive Data
12 May 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence attends RBC Global Healthcare Conference
07 May 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Notice of AGM
04 May 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence Support International Thalassemia Day
30 Apr 2021 4:12 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
29 Apr 2021 5:58 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
  7:00 am RNS Factsheet Silence Therapeutics (SLN) First patient dosed in GEMINI II
28 Apr 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence Achieves Research Milestone Payment
27 Apr 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Grant of Employee Options
19 Apr 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Purchase of ADS and PDMR Shareholding
15 Apr 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Publication in Cardiovascular Research
07 Apr 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence to Present at Virtual Needham Conference
30 Mar 2021 6:13 pm RNS Factsheet Silence Therapeutics (SLN) Silence Therapeutics Publication of Annual Report
  9:04 am RNS Factsheet Silence Therapeutics (SLN) REPLACEMENT Silence Reports Full-year 2020 Results
26 Mar 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Block Listing Application
04 Mar 2021 7:29 am RNS Factsheet Silence Therapeutics (SLN) Silence presents at Barclays Healthcare Conference
01 Mar 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Notice of Annual Results
26 Feb 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence & Mallinckrodt Initiate Work on 3rd Target
24 Feb 2021 3:09 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
22 Feb 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence to Partake in March Investor Conferences
18 Feb 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) Silence to present at SVB Leerink Conference
17 Feb 2021 7:00 am RNS Factsheet Silence Therapeutics (SLN) First dosing for SLN360
15 Feb 2021 3:55 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
  1:14 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
12 Feb 2021 4:57 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
  4:53 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
  12:10 pm RNS Factsheet Silence Therapeutics (SLN) Additional Listing and Total Voting Rights
11 Feb 2021 5:29 pm RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
  11:06 am RNS Factsheet Silence Therapeutics (SLN) Holding(s) in Company
08 Feb 2021 4:28 pm RNS Factsheet Silence Therapeutics (SLN) Additional listing and Total Voting Rights


Company Announcements Archive »


a d v e r t i s e m e n t